Onkure Therapeutics Releases Q2 2026 Financial Results
AlphaStreet Newsdesk powered by AlphaStreet Intelligence OKUR|EPS -$0.31|Net Loss $15.3M Onkure Therapeutics Inc (OKUR) reported Q2 2026 basic and diluted ...
Monday, October 26, 2026
Tag: Therapeutics
Protagonist Therapeutics Inc. (PTGX): Billionaire Joe Edelman Likes This Stock
We just covered the Billionaire Joe Edelman’s 10 Stock Picks with Huge Upside Potential and Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ranks ...
Protagonist Therapeutics Jumps 7.0% in Broad Rally
Riding the sector wave. Protagonist Therapeutics, Inc. (NASDAQ: PTGX) surged 7.0% to $104.39 on Tuesday, April 14, 2026, as a ...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.